Literature DB >> 28497358

Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.

Afaf El-Ansary1, Geir Bjørklund2, Salvatore Chirumbolo3, Osima M Alnakhli4.   

Abstract

Autism spectrum disorder (ASD) as a neurodevelopmental disorder is characterized by impairments in social interaction, communication, and restricted, repetitive behavior. Several and reproducible studies have suggested that oxidative stress may represent one of the primary etiological mechanism of ASD that can be targeted for therapeutic intervention. In the present study, multiple regression and combined receiver operating characteristic (ROC) analysis were used to search for a relationship between impaired energy and oxidative metabolic pathways in the etiology of ASD and to find the linear combination that maximizes the partial area under a ROC curve for a pre-identified set of markers related to energy metabolism and oxidative stress. Thirty children with ASD and 30 age and gender matched controls were enrolled in the study. Using either spectrophotometric or ELISA-colorimetric assay, levels of lipid peroxides, vitamin E, vitamin C, glutathione (GSH)/glutathione disulfide (GSSG) together with the enzymatic activity of catalase, plasma glutathione peroxidase (GPx), and blood superoxide dismutase (SOD), were measured in peripheral blood samples, as biomarkers related to oxidative stress. Creatine kinase, ectonucleotidases (ADPase and ATPase) Na+/K+ (ATPase), lactate, inorganic phosphate, and levels of adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP) together with adenylate energy charge, were also measured as markers of impaired energy metabolism. Statistical analysis using ROC curves, multiple and logistic regression were performed. A remarkable increase in the area under the curve for most of the combined markers, representing both energy impaired metabolism or oxidative stress, was observed by using combined ROC analyses. Moreover, higher specificity and sensitivity of the combined markers were also reported. The present study indicated that the measurement of the predictive value of selected biomarkers related to energy metabolism and oxidative stress in children with ASD using ROC analysis should lead to the better identification of the etiological mechanism of ASD associated with metabolism and diet. Agents with activity against the impaired metabolic pathway associated with ASD including the metabolic defects and involved enzymes hold a promise as a novel therapy for ASD.

Entities:  

Keywords:  Autism; Autistic children; Oxidative stress; ROC analysis; ROC curve

Mesh:

Substances:

Year:  2017        PMID: 28497358     DOI: 10.1007/s11011-017-0029-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  44 in total

1.  Identification and validation of biomarkers for autism spectrum disorders.

Authors:  Eva Loth; Will Spooren; Lindsay M Ham; Maria B Isaac; Caroline Auriche-Benichou; Tobias Banaschewski; Simon Baron-Cohen; Karl Broich; Sven Bölte; Thomas Bourgeron; Tony Charman; David Collier; Fernando de Andres-Trelles; Sarah Durston; Christine Ecker; Andre Elferink; Marion Haberkamp; Robert Hemmings; Mark H Johnson; Emily J H Jones; Omar S Khwaja; Sabine Lenton; Luke Mason; Valentina Mantua; Andreas Meyer-Lindenberg; Michael V Lombardo; Laurence O'Dwyer; Koichi Okamoto; Gahan J Pandina; Luca Pani; Antonio M Persico; Emily Simonoff; Sitra Tauscher-Wisniewski; Jordi Llinares-Garcia; Spiros Vamvakas; Steve Williams; Jan K Buitelaar; Declan G M Murphy
Journal:  Nat Rev Drug Discov       Date:  2016-01       Impact factor: 84.694

2.  Diagnostic methods I: sensitivity, specificity, and other measures of accuracy.

Authors:  Karlijn J van Stralen; Vianda S Stel; Johannes B Reitsma; Friedo W Dekker; Carmine Zoccali; Kitty J Jager
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

3.  Extracellular mitochondrial ATP, suramin, and autism?

Authors:  Theoharis C Theoharides
Journal:  Clin Ther       Date:  2013-08-15       Impact factor: 3.393

4.  Multiple presentation of mitochondrial disorders.

Authors:  A Nissenkorn; A Zeharia; D Lev; A Fatal-Valevski; V Barash; A Gutman; S Harel; T Lerman-Sagie
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study.

Authors:  Emiko Fujii; Kenji Mori; Masahito Miyazaki; Toshiaki Hashimoto; Masafumi Harada; Shoji Kagami
Journal:  J Med Invest       Date:  2010-02

6.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

7.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.

Authors:  S Takamori; J S Rhee; C Rosenmund; R Jahn
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Authors:  Todd B Sherer; Ranjita Betarbet; Amy K Stout; Serena Lund; Melisa Baptista; Alexander V Panov; Mark R Cookson; J Timothy Greenamyre
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

9.  Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes.

Authors:  Feng Gu; Ved Chauhan; Abha Chauhan
Journal:  Free Radic Biol Med       Date:  2013-07-26       Impact factor: 7.376

10.  Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain.

Authors:  S Rose; S Melnyk; O Pavliv; S Bai; T G Nick; R E Frye; S J James
Journal:  Transl Psychiatry       Date:  2012-07-10       Impact factor: 6.222

View more
  20 in total

1.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

2.  Loss of neurexin-1 in Drosophila melanogaster results in altered energy metabolism and increased seizure susceptibility.

Authors:  Kyra A Levy; Eliana D Weisz; Thomas A Jongens
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

3.  Altered Metabolic Characteristics in Plasma of Young Boys with Autism Spectrum Disorder.

Authors:  Lei Wang; Ruixuan Zheng; Ying Xu; Ziyun Zhou; Ping Guan; Yanling Wu; Jian Zhou; Zaohuo Cheng; Lili Zhang
Journal:  J Autism Dev Disord       Date:  2021-11-20

Review 4.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

5.  The Independent and Combined Effects of Omega-3 and Vitamin B12 in Ameliorating Propionic Acid Induced Biochemical Features in Juvenile Rats as Rodent Model of Autism.

Authors:  Hanan Alfawaz; Mona Al-Onazi; Sarah I Bukhari; Manal Binobead; Nashwa Othman; Norah Algahtani; Ramesa Shafi Bhat; Nadine M S Moubayed; Haya S Alzeer; Afaf El-Ansary
Journal:  J Mol Neurosci       Date:  2018-10-04       Impact factor: 3.444

Review 6.  Emerging biomarkers in autism spectrum disorder: a systematic review.

Authors:  Richard E Frye; Sarah Vassall; Gurjot Kaur; Christina Lewis; Mohammand Karim; Daniel Rossignol
Journal:  Ann Transl Med       Date:  2019-12

Review 7.  Oxidative Stress in Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Mona A El-Bana; Alexey A Tinkov; Khaled Saad; Maryam Dadar; Maha Hemimi; Anatoly V Skalny; Božena Hosnedlová; Rene Kizek; Joško Osredkar; Mauricio A Urbina; Teja Fabjan; Amira A El-Houfey; Joanna Kałużna-Czaplińska; Paulina Gątarek; Salvatore Chirumbolo
Journal:  Mol Neurobiol       Date:  2020-02-05       Impact factor: 5.590

8.  Sympathetic, Metabolic Adaptations, and Oxidative Stress in Autism Spectrum Disorders: How Far From Physiology?

Authors:  Antonietta Messina; Vincenzo Monda; Francesco Sessa; Anna Valenzano; Monica Salerno; Ilaria Bitetti; Francesco Precenzano; Rosa Marotta; Francesco Lavano; Serena M Lavano; Margherita Salerno; Agata Maltese; Michele Roccella; Lucia Parisi; Roberta I Ferrentino; Gabriele Tripi; Beatrice Gallai; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina; Marco Carotenuto
Journal:  Front Physiol       Date:  2018-03-22       Impact factor: 4.566

9.  Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial.

Authors:  James B Adams; Tapan Audhya; Elizabeth Geis; Eva Gehn; Valeria Fimbres; Elena L Pollard; Jessica Mitchell; Julie Ingram; Robert Hellmers; Dana Laake; Julie S Matthews; Kefeng Li; Jane C Naviaux; Robert K Naviaux; Rebecca L Adams; Devon M Coleman; David W Quig
Journal:  Nutrients       Date:  2018-03-17       Impact factor: 5.717

10.  Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.

Authors:  Sergio Modafferi; Xiali Zhong; Andre Kleensang; Yohei Murata; Francesca Fagiani; David Pamies; Helena T Hogberg; Vittorio Calabrese; Herbert Lachman; Thomas Hartung; Lena Smirnova
Journal:  Environ Health Perspect       Date:  2021-07-14       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.